Avidity Biosciences, Inc. (RNA) NASDAQ

49.01

+1.12(+2.34%)

Updated at October 20 04:00PM

Currency In USD

Valuation

Market Cap3.24B
Enterprise Value3.03B
P/E Ratio-13.94
PEG Ratio0.76
Price/Sales Ratio587.71
Price/Book Ratio5.33
Enterprise/Revenue565.46
Enterprise/EBITDA-11.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-42.48
Operating Margin-48.63

Management Effectiveness

Return On Assets-0.33
Return On Equity-0.33

Income Statement

Revenue10.9M
Revenue/Share0.08
Gross Profit10.9M
EBITDA-376.16M
Net Income-322.3M
Diluted EPS-2.89

Balance Sheet

Total Cash1.18B
Total Cash/Share9.13
Total Debt5.14M
Total Debt/Equity0
Current Ratio9.26
Book Value Per Share9.2

Price History

52-Week Change4.92
52-Week High56
52-Week Low21.51
Moving Average 50 Days45.59
Moving Average 200 Days34.77

Statistics

Average Volume3.16M
Shares Outstanding128.66M
% Held by Institutions104.9

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A